Abstract
The aim of this study was to evaluate possible associations between potential risk factors and the occurrence of established vertebral fractures (VF) in Mexican patients with systemic lupus erythematosus (SLE). Consecutive patients with SLE were enrolled in a prospective, observational study from 2006 to 2015. Information on potential risk factors, including demographics, clinical data, and bone mineral density (BMD) at the lumbar spine and hip on dual-energy X-ray absorptiometry was collected at baseline and follow-up. Semiquantitative analysis was used to determine incident VF on lateral thoracic and lumbar radiographs, defined as any vertebral body graded normal at baseline and at least mildly deformed (20–25% reduction or more in any vertebral height) during follow-up. Differences in baseline characteristics were assessed in patients with and without new radiographic VF. Of 110 SLE patients included, with a median follow-up of 8 (IQR 8–9) years, 22 (20%) had radiographic VF at baseline; 35 (32%) patients had a new VF. The annual incidence rate of new morphometric VF was 3.5 (95% CI 2.4–4.91) per 100 patient/years. Most fractures were mild or moderate and biconcave shaped. Incident VF were significantly associated with baseline BMD at the total hip and longer disease duration. Cumulative glucocorticoid dose, postmenopausal status, and previous prevalent VF were not associated with VF. In this SLE cohort in daily clinical practice, new VF were frequently present in SLE patients, especially those with longer disease duration and low-hip BMD.


Similar content being viewed by others
References
Lems WF (2007) Clinical relevance of vertebral fractures. Ann Rheum Dis 66:2–4. doi:10.1136/ard.2006.058313
Black DM, Arden NK, Palermo L et al (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14:821–828. doi:10.1359/jbmr.1999.14.5.821
Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323
Borba VZC, Matos PG, da Silva Viana PR et al (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529–533. doi:10.1191/0961203305lu2154oa
Weiss RJ, Wick MC, Ackermann PW, Montgomery SM (2010) Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases: a case-control study with 53,108 patients with fracture. J Rheumatol 37:2247–2250. doi:10.3899/jrheum.100363
Li EK, Tam LS, Griffith JF et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646–1652. doi:10.3899/jrheum.081337
Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H et al (2009) Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 28:579–585. doi:10.1007/s10067-009-1105-3
Furukawa M, Kiyohara C, Horiuchi T et al (2013) Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus. Mod Rheumatol 23:765–773. doi:10.1007/s10165-012-0735-5
Bultink IEM, Lems WF, Kostense PJ et al (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050. doi:10.1002/art.21110
Almehed K, Hetenyi S, Ohlsson C et al (2010) Prevalence and risk factors of vertebral compression fractures in female SLE patients. Arthritis Res Ther 12:R153. doi:10.1186/ar3104
Zhu T, Griffith J, Au S-K et al (2014) Incidence of and risk factors for non-vertebral and vertebral fracture in female Chinese patients with systemic lupus erythematosus: a five-year cohort study. Lupus. doi:10.1177/0961203314528555
Yeap SS, Fauzi AR, Kong NCT et al (2008) A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol 35:2344–2347. doi:10.3899/jrheum.080634
Seno T, Yamamoto A, Kukida Y et al (2016) Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates. Springerplus 5:1056. doi:10.1186/s40064-016-2704-5
Sawamura M, Komatsuda A, Togashi M et al (2017) Effects of denosumab on bone metabolic markers and bone mineral density in patients treated with glucocorticoids. Intern Med 56:631–636. doi:10.2169/internalmedicine.56.7797
Feng Z, Zeng S, Wang Y et al (2013) Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. PLoS ONE 8:e80890. doi:10.1371/journal.pone.0080890
Li EK, Zhu TY, Hung VY et al (2010) Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid. Arthritis Res Ther 12:R198. doi:10.1186/ar3170
Nzeusseu Toukap A, Depresseux G, Devogelaer J-P, Houssiau FA (2005) Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients. Lupus 14:517–520. doi:10.1191/0961203305lu2149oa
Lambrinoudaki I, Chan DT, Lau CS et al (2000) Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study. J Rheumatol 27:1759–1765
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. doi:10.1002/1529-0131(199709)40:9<1725:AID-ART29>3.0.CO;2-Y
Guzman J, Cardiel MH, Arce-Salinas A et al (1992) Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 19:1551–1558
Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281. doi:10.1056/NEJMra070553
Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry. J Clin Densitom 16:455–466. doi:10.1016/j.jocd.2013.08.004
Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148. doi:10.1002/jbmr.5650080915
Felsenberg D, Silman AJ, Lunt M et al (2002) Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17:716–724. doi:10.1359/jbmr.2002.17.4.716
Vis M, Haavardsholm EA, Bøyesen P et al (2011) High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int 22:2413–2419. doi:10.1007/s00198-010-1517-6
Woo J, Li M, Lau E (2001) Population bone mineral density measurements for Chinese women and men in Hong Kong. Osteoporos Int 12:289–295. doi:10.1007/s001980170118
Xiaoge D, Eryuan L, Xianping W et al (2000) Bone mineral density differences at the femoral neck and Ward’s triangle: a comparison study on the reference data between Chinese and Caucasian women. Calcif Tissue Int 67:195–198
Walker MD, Babbar R, Opotowsky AR et al (2006) A referent bone mineral density database for Chinese American women. Osteoporos Int 17:878–887. doi:10.1007/s00198-005-0059-9
Xu L, Lu A, Zhao X et al (1996) Very low rates of hip fracture in Beijing, People’s Republic of China the Beijing Osteoporosis Project. Am J Epidemiol 144:901–907
Lauderdale DS, Jacobsen SJ, Furner SE et al (1997) Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol 146:502–509
Lau EM, Chan HH, Woo J et al (1996) Normal ranges for vertebral height ratios and prevalence of vertebral fracture in Hong Kong Chinese: a comparison with American Caucasians. J Bone Miner Res 11:1364–1368. doi:10.1002/jbmr.5650110922
Barrett-Connor E, Siris ES, Wehren LE et al (2005) Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 20:185–194. doi:10.1359/JBMR.041007
Lee C, Almagor O, Dunlop DD et al (2007) Association between African American race/ethnicity and low bone mineral density in women with systemic lupus erythematosus. Arthritis Rheum 57:585–592. doi:10.1002/art.22668
Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ 3rd (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7:221–227. doi:10.1002/jbmr.5650070214
Melton LJ 3rd, Lane AW, Cooper C et al (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3:113–119
Briggs AM, Greig AM, Wark JD (2007) The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int 18:575–584. doi:10.1007/s00198-006-0304-x
Almehed K, Hetényi S (2010) Prevalence and risk factors of vertebral compression fractures in female SLE patients. Arthritis Res Ther 12(4):153
Stoll D, Dudler J, Lamy O et al (2011) High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population. Swiss Med Wkly 141:w13196. doi:10.4414/smw.2011.13196
Mehat P, Atiquzzaman M, Esdaile JM et al (2017) Medication non-adherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken). doi:10.1002/acr.23191
Angeli A, Guglielmi G, Dovio A et al (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39:253–259. doi:10.1016/j.bone.2006.02.005
Van Staa TP, Laan RF, Barton IP et al (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224–3229. doi:10.1002/art.11283
Bultink IEM, Lems WF (2015) Systemic lupus erythematosus and fractures. RMD Open 1:e000069. doi:10.1136/rmdopen-2015-000069
Lems WF, Jahangier ZN, Jacobs JW, Bijlsma JW (1995) Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol 13:293–297
de Nijs RN, Jacobs JW, Bijlsma JW et al (2001) Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology 40:1375–1383
Frediani B, Falsetti P, Bisogno S et al (2004) Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. J Rheumatol 31:1083–1087
Bultink IEM (2012) Osteoporosis and fractures in systemic lupus erythematosus. Arthritis Care Res 64:2–8. doi:10.1002/acr.20568
Schousboe JT, Fink HA, Taylor BC et al (2005) Association between self-reported prior wrist fractures and risk of subsequent hip and radiographic vertebral fractures in older women: a prospective study. J Bone Miner Res 20:100–106. doi:10.1359/JBMR.041025
Ismail AA, O’Neill TW, Cockerill W et al (2000) Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int 11:248–254
Genant HK, Jergas M (2003) Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporos Int 14(Suppl 3):S43–S55. doi:10.1007/s00198-002-1348-1
Acknowledgements
The authors would like to thank all patients who participated in this study for their patience and understanding. We would like to thank David Buss for his valuable guidance and advice during this project. This work was in part supported by a grant from “Programa para el Desarrollo Profesional Docente, para el Tipo Superior” (SEP-PRODEP) “Integración de redes temáticas de colaboración académica”.
Funding
This work was supported in part by grant from FIS/IMSS/PROT/MD15/1500. This funding source had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Mario García-Carrasco, Claudia Mendoza-Pinto, María de la Luz León-Vázquez, Socorro Méndez-Martínez, Ivet Etchegaray-Morales, Álvaro Montiel-Jarquín, Miguel Angel Enriquez-Guerra, Margarita Muñóz-Guarneros, José Luis Gálvez-Romero, Pamela Soto-Santillán and Ricard Cervera declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
The study was reviewed and approved by our local institutional ethics committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the Helsinki declaration.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
García-Carrasco, M., Mendoza-Pinto, C., León-Vázquez, M.d. et al. Incidence of Vertebral Fractures in Women with Systemic Lupus Erythematosus After 8 Years of Follow-Up. Calcif Tissue Int 101, 291–299 (2017). https://doi.org/10.1007/s00223-017-0286-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-017-0286-z